2/10/2026 2:42:29 PM Woes for the manufacturer of Ozempic and Wegovy: a warning about the longevity of IP assets in business plans By Christopher Pollard Novo Nordisk is currently struggling to stem the flow of its haemorrhaging share price. The rationale seems to be that it is entering a...
2/3/2026 6:26:41 PM Joanna Jenson's cautionary tale on IP rights By Christopher Pollard I read a brilliantly written article by Joanna Jenson (founder of skincare brand Childs Farm) regarding the importance of IP protection...
1/29/2026 9:42:30 AM AI and the Music Industry – industry led deals outpacing regulation By Lakmal Walawage Ruby Clarke In our recent legal update, which can be found here, we discussed the likelihood that in the absence of adequate regulation, major record...